131 related articles for article (PubMed ID: 8819893)
1. Alterations in intestinal transport of oxalate in disease states.
Hatch M; Freel RW
Scanning Microsc; 1995; 9(4):1121-6; discussion 1126. PubMed ID: 8819893
[TBL] [Abstract][Full Text] [Related]
2. Effect of bile salts and fatty acids on the colonic absorption of oxalate.
Dobbins JW; Binder HJ
Gastroenterology; 1976 Jun; 70(6):1096-1100. PubMed ID: 1269869
[TBL] [Abstract][Full Text] [Related]
3. [Hyperoxaluria and renal calculi].
Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
[TBL] [Abstract][Full Text] [Related]
4. The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man.
Whittamore JM; Hatch M
Urolithiasis; 2017 Feb; 45(1):89-108. PubMed ID: 27913853
[TBL] [Abstract][Full Text] [Related]
5. Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice.
Freel RW; Hatch M; Green M; Soleimani M
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G719-28. PubMed ID: 16373425
[TBL] [Abstract][Full Text] [Related]
6. Role of cecal pH in intestinal oxalate absorption in the rat.
Diamond KL; Fox CC; Barch DH
J Lab Clin Med; 1988 Sep; 112(3):352-6. PubMed ID: 3411198
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II involvement in adaptive enteric oxalate excretion in rats with chronic renal failure induced by hyperoxaluria.
Hatch M; Freel RW
Urol Res; 2003 Dec; 31(6):426-32. PubMed ID: 14574528
[TBL] [Abstract][Full Text] [Related]
8. [Clinical aspects of oxalate metabolism].
Balcke P
Infusionsther Klin Ernahr; 1983 Dec; 10(6):318-21. PubMed ID: 6662594
[TBL] [Abstract][Full Text] [Related]
9. Regulatory aspects of oxalate secretion in enteric oxalate elimination.
Hatch M; Freel RW; Vaziri ND
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S324-8. PubMed ID: 10541256
[TBL] [Abstract][Full Text] [Related]
10. Dietary oxalate and its intestinal absorption.
Holmes RP; Goodman HO; Assimos DG
Scanning Microsc; 1995; 9(4):1109-18; discussion 1118-20. PubMed ID: 8819892
[TBL] [Abstract][Full Text] [Related]
11. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals.
Huang HS; Ma MC; Chen J; Chen CF
Neurourol Urodyn; 2003; 22(2):176-82. PubMed ID: 12579636
[TBL] [Abstract][Full Text] [Related]
12. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
[TBL] [Abstract][Full Text] [Related]
13. Enhanced gastrointestinal passive paracellular permeability contributes to the obesity-associated hyperoxaluria.
Bashir M; Meddings J; Alshaikh A; Jung D; Le K; Amin R; Ratakonda S; Sharma S; Granja I; Satti M; Asplin J; Hassan H
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G1-G14. PubMed ID: 30307745
[TBL] [Abstract][Full Text] [Related]
14. Renal and intestinal handling of oxalate following oxalate loading in rats.
Hatch M; Freel RW
Am J Nephrol; 2003; 23(1):18-26. PubMed ID: 12373077
[TBL] [Abstract][Full Text] [Related]
15. The management of patients with enteric hyperoxaluria.
Asplin JR
Urolithiasis; 2016 Feb; 44(1):33-43. PubMed ID: 26645872
[TBL] [Abstract][Full Text] [Related]
16. Intestinal excretion of oxalate in chronic renal failure.
Hatch M; Freel RW; Vaziri ND
J Am Soc Nephrol; 1994 Dec; 5(6):1339-43. PubMed ID: 7893999
[TBL] [Abstract][Full Text] [Related]
17. Net intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretion.
Knauf F; Ko N; Jiang Z; Robertson WG; Van Itallie CM; Anderson JM; Aronson PS
J Am Soc Nephrol; 2011 Dec; 22(12):2247-55. PubMed ID: 22021714
[TBL] [Abstract][Full Text] [Related]
18. Intestinal adaptations in chronic kidney disease and the influence of gastric bypass surgery.
Hatch M
Exp Physiol; 2014 Sep; 99(9):1163-7. PubMed ID: 24951497
[TBL] [Abstract][Full Text] [Related]
19. [Pancreatico-biliary secretion in enteral hyperoxaluria].
Möller T; Appelt G; Müller G; Rogos R; Schütte W; Wegner D
Dtsch Z Verdau Stoffwechselkr; 1988; 48(6):315-20. PubMed ID: 3254836
[TBL] [Abstract][Full Text] [Related]
20. Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.
Amin R; Asplin J; Jung D; Bashir M; Alshaikh A; Ratakonda S; Sharma S; Jeon S; Granja I; Matern D; Hassan H
Kidney Int; 2018 May; 93(5):1098-1107. PubMed ID: 29395336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
